Concepedia

Carla Maciag

CM

14

Publications

782

Citations

14

H-Index

1994

Active since

Affiliations

AstraZeneca (United States)(Current)

Wilmington University

Experimental Station

Sage Therapeutics (United States)

DuPont (United States)

Carla Maciag is an author at AstraZeneca (United States) specializing in neuropharmacology, medicine, and pharmacology.

Top concepts

Publications per year

1994–2017

14

Publications

14

Two New Potent Neurotransmitter Release Enhancers, 10,10-Bis(4-Pyridinylmethyl)-9(10H)-Anthracenone and 10,10-Bis(2-Fluoro-4-Pyridinylmethyl)-9(10H)-Anthracenone: Comparison to Linopirdine

Robert Zaczek, Robert J. Chorvat, J Saye et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 130 citations

Selective α7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes

S G Sydserff, Evelynjeane J. Sutton, Dekun Song et al. · Biochemical Pharmacology · 2009 · 96 citations

, , +11

Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor

Siew Peng Ho, Lorey K. Takahashi, Valentin Livanov et al. · Molecular Brain Research · 2001 · 80 citations

, , +14

A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression

Erica M. Richards, Daniel C. Mathews, David A. Luckenbaugh et al. · Psychopharmacology · 2016 · 70 citations · Full text

, , +10

EEG-β/γ spectral power elevation in rat: a translatable biomarker elicited by GABA<sub>Aα2/3</sub>-positive allosteric modulators at nonsedating anxiolytic doses

Edward P. Christian, Dean H. Snyder, Wei Song et al. · Journal of Neurophysiology · 2014 · 63 citations

, , +24

Rows per page

1–5 of 14